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Obesity is related to the consumption of energy-dense foods in addition to changes 
in the microbiome where a higher abundance of gut Bacteroidetes can be found in 
lean subjects or after weight loss. Lactitol, a sweet-tasting sugar alcohol, is a common 
sugar-replacement in foods. Polydextrose (PDX), a highly branched glucose polymer, is 
known to reduce energy intake. Here, we test if the combined effects of lactitol or PDX 
in combination with Bacteroides species will have a beneficial metabolic response in rats 
fed a high-fat (HF) diet. A total of 175 male Wistar rats were fed either a LF or HF diet. 
Bacteroides thetaiotaomicron (1010 bacteria/animal/day) was orally administered with or 
without lactitol (1.6−2 g/animal/day) or PDX (2 g/animal/day) for 8 days. Postprandial 
blood samples, cecal digesta, and feces were collected on the last day. Measurements 
included: body weight, feed consumption, cecal short-chain fatty acids, fecal dry matter 
and heat value, blood glucose, insulin, triglyceride, and satiety hormone concentrations. 
Lactitol and PDX decreased the mean body weight when administered with B. the-
taiotaomicron or when lactitol was administered alone. Levels of postprandial plasma 
triglycerides declined with lactitol and PDX when administered with B. thetaiotaomicron. 
For intestinal hormone release, lactitol – alone or with B. thetaiotaomicron – increased 
the release of gastrointestinal peptide tyrosine tyrosine (PYY) as well as the area under 
the curve (AUC) measured for PYY (0–8 h). In addition, levels of insulin AUC (0–8 h) 
decreased in the lactitol and PDX-supplemented groups. Lactitol and PDX may both 
provide additional means to regulate postprandial metabolism and weight management, 
whereas the addition of B. thetaiotaomicron in the tested doses had only minor effects 
on the measured parameters.
Keywords: Bacteroides, insulin, lactitol, obesity, polydextrose, PYY, satiety signals, triglycerides
Abbreviations: AUC, area under the curve; BCFA, branched-chain fatty acid; BWG, body weight gain; CCK, cholecystokinin; 
GLP-1, glucagon-like peptide-1; HF, high fat; LF, low fat; PDX, polydextrose; PYY, peptide tyrosine tyrosine; qPCR, quantitative 
polymerase chain reaction; SCFA, short-chain fatty acid.
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inTrODUcTiOn
Managing postprandial glucose and lipid responses can decrease 
the risk of metabolic diseases and influence body weight 
management. Therefore, low glycemic and satiety-increasing 
food components, such as non-starch polysaccharides, have 
been studied for their impact on energy metabolism and 
satiety (1). Several studies have also demonstrated that the gut 
microbiota contributes to the control of body weight and energy 
 homeostasis (2, 3).
Lactitol, a sweet-tasting sugar alcohol that consists of galactose 
and sorbitol, is commonly used in low-calorie products to replace 
sucrose. Lactitol is not absorbed in the small intestine or hydro-
lyzed by gastrointestinal tract enzymes but, unlike polydextrose 
(PDX), it is metabolized rapidly by the gastrointestinal microbes 
[for review, see Ref. (4)]. PDX is a highly branched, randomly 
bonded glucose polymer and its structural complexity prevents 
its hydrolysis by mammalian enzymes in the upper gastrointes-
tinal tract. PDX is widely recognized as a soluble fiber (5) and 
due to its very low energy density, PDX might reduce energy 
intake and influence the gastrointestinal microbiome. As PDX 
passes through the small intestine, it is partially metabolized by 
the colonic microbes (6). A sustained degradation of PDX has 
been demonstrated also throughout a four-stage colon simulation 
model (7). In human studies, PDX has already shown to enhance 
satiety and reduce energy intake during a sequential ad libitum 
lunch (8–10).
Most of the ingested lactitol and part of the PDX are fermented 
by the microbiota in the lower gastrointestinal tract producing 
short-chain fatty acids (SCFAs) (4, 7, 11), which stimulate gas-
trointestinal peptide secretion, such as peptide tyrosine tyrosine 
(PYY), glucagon-like peptide-1 (GLP-1), and cholecystokinin 
(CCK) from enteroendocrine cells (12, 13). These peptides 
control intestinal secretion and motility, i.e., function as ileal 
brake, in addition to the central inhibition of food intake. PYY 
has also shown to increase energy expenditure and fat oxidation 
in humans and rodents (14). Previous animal studies have shown 
that lactitol stimulates PYY and GLP-1 secretion (15). Lactitol 
and synbiotics, such as Lactobacillus delbrueckii subsp. rhamnosus 
strain GG, and Bifidobacterium lactis Bp12 have increased plasma 
PYY concentrations in animals (15, 16). SCFAs injected directly 
into the rat colon have been shown to increase the release of PYY 
(17, 18). In humans, the oral intake of SCFAs and colonic delivery 
of SCFAs via fermentable dietary fiber stimulated PYY and GLP-1 
release, although contradictory effects on appetite and satiety 
sensation have been observed (19, 20).
It is now well established that obesity is associated with changes 
in the microbiome, especially the relative abundance of the two 
dominant bacterial divisions, the Firmicutes and the Bacteroidetes. 
The gut microbiota of genetically obese (ob/ob) mice had an 
increased abundance of Firmicutes over Bacteroidetes (21). An 
increase in the relative abundance of Bacteroidetes has been cor-
related to weight loss (22). Evidently, the high-fat (HF)-enriched 
Western diet provides a competitive advantage to the Firmicutes 
(23). Cani et  al. have proposed that the amount of beneficial 
bifidobacteria in the gut differ according to the state of obesity, 
showing lower bacterial counts in obese and higher counts in lean 
subjects (24). Both lactitol and PDX possess prebiotic properties, 
and lactitol can increase the quantity of beneficial bacteria, such 
as lactobacilli and bifidobacteria (25). An increase in the number 
of these beneficial intestinal bacteria has also been demonstrated 
in human trials after the use of PDX alone (4 g/day) (26) and in 
combination with a probiotic bacteria mixture (27) or another 
prebiotic (28). The effect of Bacteroidetes on satiety is still unclear, 
although the higher relative abundance of gut Bacteroidetes is 
repeatedly being reported with lean subjects or after weight loss 
(29). In a recent study in rats, the addition of prebiotics was able 
to normalize the reduced amount of Bacteroidetes often reported 
in obesity (30). Prebiotics have also raised the concentration of 
plasma PYY and the cecum mRNA levels of PYY (31).
Therefore, we tested the combined effects of two carbohy-
drates and Bacteroides species in a large animal trial hypothesiz-
ing that the supplementation of Bacteroides inoculum might 
affect the weight gain in rats fed a HF diet, Furthermore, this 
effect could be modified by the addition of synbiotic effects 
of lactitol or PDX. The use of a combination of intestinal 
Bacteroides species, Bacteroides thetaiotaomicron, and two dif-
ferent indigestible carbohydrates, such as lactitol or PDX, has 
not been studied before.
MaTerials anD MeThODs
animals and experimental Design
A total of 175 male Wistar (HsdBrlHan:WIST) rats (Harlan, 
The Netherlands) were used in this study. The experiments 
were approved by the Regional State Administrative Agency of 
Southern Finland and were conducted under the animal license 
number ESLH-2008-03964. Institutional and national guidelines 
for the care and use of animals were followed. Animals arrived 
at the age of approximately 8 weeks were housed in plastic cages 
(Makrolon 3, Tecniplast, Bayer MaterialScience AG, Leverkusen, 
Germany), two to three per cage (floor area 814 cm2), and were 
kept in a conventional animal room with reversed artificial 12 h 
light/dark cycle (21 ± 3°C, 55 ± 15% humidity). The animals were 
randomly assigned to different groups and they were acclimatized 
with their respective diets for 2 weeks before the first dosage of 
test items. The animals were trained to consume their food within 
5 h from the start of the dark cycle.
The first experiment (Experiment A) studied whether 
Bacteroides supplementation can affect satiety and how the 
responses differ between animals fed a low-fat (LF) or a HF 
diet. The latter experiment (Experiment B) evaluated the effects 
of lactitol and PDX – administered separately, or together with 
B.  thetaiotaomicron inoculum – on weight gain, satiety signals, 
and other metabolic parameters in rats fed a HF diet.
Experiment A
The animal trial set-up and the arrangement of different treat-
ment groups are presented in Figure 1.
Animals were randomly allocated into five study groups 
(I–V), 15 animals in each group. Two different diets were used: 
RM 1 (E) diet (Rat and Mouse Maintenance diet, product code: 
801002, Special Diet Services, Witham, UK) was used for the 
TaBle 1 | The composition of the experimental diets.
experiment a experiment B
lF (rM 1) hF (Western rD) hF (Western rD)
Carbohydrates (% cal) 75.09 43 43
Protein (% cal) 17.49 15 15
Fat (% cal) 7.42 42 42
Fiber (%) 4.65 3.5 3.5
cal, calorie; HF, high-fat diet; LF, low-fat diet; RD, rat diet; RM, rat and mouse 
maintenance diet.
FigUre 1 | a flow chart outlining the progression of the animal trials and the arrangement of different treatment groups in experiments a (a) and B 
(B). 0.9% NaCl functioned as a control vehicle. HF, high-fat diet; LF, low-fat diet; PDX, polydextrose; RD, Rat Diet; RM, rat and mouse maintenance diet.
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study groups I and II and Western RD (P) diet (Western Rat 
Diet, product code: 829100, Special Diet Services, Witham, 
UK) for the study groups III–V. The RM 1 diet contained 7.42% 
calories from fat and the Atwater fuel energy was 13.75 MJ/kg. 
The Western RD diet contained 42% calories from fat and the 
Atwater fuel energy was 19.35 MJ/kg. Therefore, the diets were 
named LF and HF, respectively (Table 1). Study groups I and III 
were dosed with a vehicle (0.9% NaCl), groups II and IV with B. 
thetaiotaomicron (1010 bacteria/animal/day) in 0.9% NaCl, and 
group V with lactitol (1.6–1.8 g/animal/day) (Danisco USA Inc., 
Thomson, IL, USA) in sterile water. B. thetaiotaomicron (DSM 
2079) was pre-cultured over-night in cooked Meat Medium 
(Difco, Le Pont de Claix, France) and then cultivated anaerobi-
cally over-night in MRS medium (Lab M Limited, Lancashire, 
UK). The test items used in conjunction with B. thetaiotaomicron 
were prepared in advance and stored at −20°C until the dos-
age. Lactitol was dissolved in sterile water on the day of the 
dosage. All test items and the control vehicle were dosed per os 
and administered by oral gavage using Teflon feeding needles 
(AgnTho’s, Lidingö, Sweden) for 8 days with a volume of 2 ml/
rat/day. On study days 1–7, the dosage was carried out in the 
morning just before feeding period (dark cycle), after which 
the feed was available ad  libitum for 5  h. On study day 8, the 
dosage took place within 2 h before the onset of the dark cycle 
and the animals were given feed ad libitum immediately after the 
dosage. The feed consumption was measured from each separate 
cage for 7 days during an acclimatization period and on study 
days 1–7 (n = 5, three animals per cage). Some minor spillage 
of feed might have occurred through the cage bars and was not 
recorded. Feed intake was calculated as consumption per 100 g 
of body weight.
Experiment B
Animals were allocated into four study groups (I–IV), 25 animals 
in each group. The HF diet (Western Rat Diet (P), 829100, Special 
Diet Services, Witham, UK) (Table 1) was used for all study groups 
throughout Experiment B. Study group I was dosed with a control 
vehicle (0.9% NaCl) and groups II–IV with B. thetaiotaomicron 
(DSM 2079) (1010 bacteria/animal/day) in 0.9% NaCl. In addition 
to B. thetaiotaomicron, groups III and IV received lactitol (2 g/
animal/day) (Danisco USA Inc., Thomson, IL, USA) or PDX 
(2 g/animal/day) (Litesse® Ultra, Danisco USA Inc., Terre Haute, 
IN, USA), respectively. The test item preparation and the dosage 
(2 ml/animal/day) were conducted and feed intake (n = 10, two 
to three animals per cage) calculated as described in Experiment 
A. The feed was available for 5 h after the last dose was given.
short-chain Fatty acids
Following terminal blood sampling, digesta samples (content of 
cecum) were taken from all animals, frozen and stored at below 
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−18°C. Gas chromatographic analysis of the SCFAs (acetic acid, 
propionic acid, butyric acid, isobutyric acid, valeric acid, isovaleric 
acid, 2-methylbutyric acid) and lactic acid in the rat cecal digesta 
samples was performed using pivalic acid as an internal standard 
as described previously (32). SCFAs are expressed as micromole/
gram wet weight.
Dry Matter and heat Value of Feces
Following terminal blood sampling in Experiment B, fecal 
samples were collected from the cages (two to three rats per 
cage), pooled, frozen, and stored at below −18°C. The dry mat-
ter of feces was measured gravimetrically after drying the fecal 
samples in an oven at 105°C for 16 h. The heat value of the dried 
samples was measured using an adiabatic bomb calorimeter (Parr 
Instruments, Moline, IL, USA).
Quantification of Bacteroides spp.
Microbial DNA was extracted from the cecum digesta 
(Experiment A) or fecal samples (Experiment B) by a bead beat-
ing step before using the QIAamp DNA stool Mini kit (Qiagen, 
Hilden, Germany) according to the manufacturer’s instructions. 
Quantitative PCR (qPCR) was used to quantify the genus 
Bacteroides (including Bacteroides–Provotella–Porphyromonas) 
using the SYBR green methodology (Core reagent kit, Applied 
Biosystems, Foster City, CA, USA) in a total volume of 25 μl 
containing 10 ng of template DNA and 250 nM of the forward 
primer gBacter_F and reverse primer gBacter_R (33). The 
amplification and detection of DNA were performed with an 
ABI 7500 sequencing detection system (Applied Biosystems). 
To obtain a standard curve, a 10-fold dilution series ranging 
from 10 pg to 10 ng of DNA from the B. thetaiotaomicron (DSM 
2079) was added to the qPCR assays. For determination of DNA, 
triplicate samples were used, and the mean quantity per gram 
wet weight was calculated.
Blood analyses
The studies were designed in a way that enabled several con-
secutive blood samplings to clarify the kinetics of glucose, 
triglycerides, insulin, and gut peptides. All blood samples were 
taken from the lateral tail vein except for the terminal sam-
ples that were taken by cardiac puncture under 4% isoflurane 
anesthesia. On study day, eight blood samples (five animals 
per group) were taken into the collection tubes (Capiject® or 
Venosafe™, Terumo® Europe N.V, Leuven, Belgium, EDTA 
added as an anticoagulant) before the dosage and at 1, 3, 5, 
and 8 h after the dosage. The only exceptions were the terminal 
blood samples that were taken to vacuum tubes. The plasma 
was separated by centrifugation (1600 ×  g, 15  min, RT), and 
the plasma samples were frozen and stored at −70°C. Insulin 
and PYY were analyzed from the plasma samples using the 
MILLIPLEX™ MAP Rat Gut Hormone Panel kit (#RGT-88K, 
Millipore, Billerica, MA, USA) according to the kit manufac-
turer’s instructions. The blood glucose was determined from 
the complete blood samples (five animals per group) using the 
HemoCue® Glucose 201+ analyzer (HemoCue AB, Ängelholm, 
Sweden).
In Experiment B, the blood serum samples (10 animals 
per group) were collected for triglyceride analysis, which 
was performed with Triglycerides GPO-PAP reagent (Roche 
Diagnostics GmbH, Mannheim, Germany) and the Roche/
Hitachi MODULAR ANALYTICS measuring instrument 
(Roche Diagnostics GmbH). The serum samples were frozen at 
−20°C after sampling. Blood triglycerides were not measured in 
Experiment A.
statistical analysis
The statistical analyses were performed with Prism 5 Version 
5.01 (GraphPad Software, Inc., San Diego, CA, USA). One-way 
ANOVA or two-way ANOVA with Tukey’s multiple comparison 
test, or unpaired Student’s t-test with two-tailed distribution were 
used, as indicated in the text. For all tests, p < 0.05 was consid-
ered statistically significant. The areas under the curve (AUCs) 
of insulin and PYY were calculated using the trapezoidal rule 
and ignoring the peaks that were <10% of the distance from the 
minimum or maximum Y values.
resUlTs
Body Weight gain and Feed intake
The use of a HF diet is a common way to induce obesity in animal 
models (34). The fat and energy content of the HF diet used in this 
study (42% calories from fat) were modified so that it resembled 
the Western human diet.
Lactitol did not have any effect on the daily total fiber supply. 
However, PDX is widely recognized as soluble dietary fiber (5) and 
the commercial PDX used in this study (Litesse®) is considered 
to have 90% fiber content. The energy value of PDX is generally 
recognized as being 1 kcal/g; hence, adding in total 2 kcal/animal/
day. The energy value of lactitol is 2 kcal/g, which adds in total 
3.2–4 kcal/animal/day.
Experiment A
During the acclimatization period, the body weight gain (BWG) 
increased expectedly in all HF groups when compared to LF 
groups, and the increases in BWG were statistically significant 
(p < 0.001, one-way ANOVA) when compared to the LF control 
group (data from acclimatization period not shown). In the 
lactitol-supplemented HF group, the mean BWG declined by 39% 
during the 8-day dosing period (p < 0.001, one-way ANOVA), 
when compared to the HF control group (Figure  2A). The LF 
group supplemented with B. thetaiotaomicron did not have any 
significant effect on the mean BWG during the 8-day dosing 
period.
Lactitol had the biggest effect on feed intake with nearly a 
40% decrease in the mean feed consumption after the acclima-
tization period (p < 0.0001, Student’s t-test). In the HF control 
group and HF group supplemented with B. thetaiotaomicron, 
feed intake decreased by 19 and 18%, respectively (p < 0.0001, 
Student’s t-test). The lactitol-supplemented HF group had the 
lowest mean feed intake when compared to all other groups 
(p <  0.0001, Student’s t-test). The two LF groups showed the 
highest feed intakes among all diet groups; however, there was no 
FigUre 2 | The body weight gain (BWg) is expressed as grams separately for experiments a (a) and B (c). The actual feed intake values in both 
experiments are expressed in (B,D). The values are means with SEM represented by vertical bars (n = 15–25 for BWG, n = 5 for feed intake). Significant differences 
are marked with asterisks: ***p < 0.001 (one-way ANOVA). B. thet., Bacteroides thetaiotaomicron; HF, high-fat diet; LF, low-fat diet; PDX, polydextrose; SEM, 
standard error of the mean.
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statistically significant difference between the LF control group 
and B. thetaiotaomicron-supplemented LF group. The mean feed 
intake in the HF and LF control groups, on the other hand, dif-
fered significantly (p < 0.0001, Student’s t-test). The actual feed 
intake values in Experiment A are reported in Figure 2B.
Experiment B
In animals fed a HF diet, B. thetaiotaomicron supplementation 
alone did not have any significant effect on the mean BWG. 
However, when lactitol or PDX were administered together with 
B. thetaiotaomicron, the BWG declined by 41 and 28%, respec-
tively, when compared with the HF control group (p <  0.001, 
one-way ANOVA) (Figure 2C).
The mean feed intake was highest in the HF control and B. 
thetaiotaomicron-supplemented HF groups; however, there 
was no statistically significant difference between these two 
groups. The animals administered with the combination of 
B. thetaiotaomicron and lactitol had the lowest mean feed intake 
(p <  0.05, Student’s t-test, compared to the other HF groups). 
The PDX-supplemented HF group consumed on average less feed 
(p < 0.0001, Student’s t-test) when compared to the HF control 
group. The actual feed intake values in Experiment B are reported 
in Figure 2D.
Some soft feces were noticed in PDX and lactitol-supplemented 
groups when fecal samples were collected, and one animal per 
each of these groups had diarrhea during blood sampling.
scFas in cecum
In Experiment A, the concentrations of total SCFAs, acetic acid, 
and butyric acid were 35–65% lower in all HF diet-fed animals 
compared to the LF control animals, but the changes were not sta-
tistically significant (one-way ANOVA) (Table 2). In Experiment 
B, the total SCFA concentrations decreased by 44 and 45% in 
lactitol and PDX-treated HF groups, respectively (p  <  0.001, 
TaBle 3 | cecal concentrations of scFas (n = 10) and fecal dry matter (n = 20) and heat value (n = 20) measured 8 h after the last dose in  
experiment B.
group hF hF B. thet. hF B. thet.  lactitol hF B. thet. PDX
Mean seM Mean seM Mean seM Mean seM
cecal scFas (μmol/g)
Acetic acid 47.51 2.42 51.28 2.53 21.18*** 1.93 22.83*** 1.99
Propionic acid 11.95 0.64 12.81 0.8 10.85 1.14 9.39 0.59
Butyric acid 3.63 0.61 4.02 0.88 2.74 0.46 1.92 0.34
Lactic acid 0.31 0.17 0.69 0.2 0.9 0.2 0.43 0.28
cecal BcFas (μmol/g)
Isobutyric acid 0.43 0.05 0.52 0.05 <0.1*** 0.02 <0.1*** 0.02
2-methylbutyric acid 0.16 0.02 0.19 0.03 <0.1* 0.03 0.1 0
Isovaleric acid 0.16 0.03 0.19 0.03 <0.1*** 0.01 <0.1*** 0.01
sum of BcFas (μmol/g) 0.75 0.1 0.9 0.1 0.13*** 0.03 0.14*** 0.03
sum of all scFas (μmol/g) 64.5 3.29 69.85 3.69 35.99*** 2.93 35.18*** 2.5
Fecal dry matter (%) 77.05 1.76 76.47 1.9 62.26*** 2.12 57.68*** 2.08
Fecal heat value (KJ/g dry matter) 16.68 0.22 18.38*** 0.2 16.00 0.26 17.30 0.19
SCFAs are expressed as μmol/g wet weight. *p < 0.05, **p < 0.01, and ***p < 0.001, compared to the HF control group (ANOVA). BCFA, branched-chain fatty acid; B. thet., 
Bacteroides thetaiotaomicron; HF, high-fat diet; PDX, polydextrose; SCFA, short-chain fatty acid; SEM, standard error of the mean.
TaBle 2 | cecal concentrations of scFas (n = 5) measured 8 h after the last dose in experiment a.
group lF lF 
B. thet.
hF hF 
B. thet.
hF  
lactitol
Mean seM Mean seM Mean seM Mean seM Mean seM
scFas (μmol/g)
Acetic acid 28.42 11.92 30.66 10.89 17.26 9.42 17.70 9.66 11.83 2.62
Propionic acid 5.19 2.12 6.36 2.52 4.30 2.53 4.73 2.79 6.61 2.81
Butyric acid 21.82 12.35 19.96 11.02 13.07 3.49 13.94 4.33 7.53 2.67
Lactic acid 4.88 3.03 7.46 3.57 3.84 1.88 1.78 0.7 13.68 7.34
BcFas (μmol/g)
Isobutyric acid nd nd nd nd nd
2-methylbutyric acid <0.1 0.09 0.14 0.1 0.16 0.07 0.18 0.08 0.13 0.04
Isovaleric acid 0.16 0.11 0.17 0.12 0.17 0.11 0.17 0.11 <0.1 0.03
sum of BcFas (μmol/g) 0.16 0.2 0.31 0.21 0.33 0.16 0.35 0.18 0.13 0.03
sum of all scFas (μmol/g) 60.44 23.65 64.70 20.37 38.73 7.94 38.42 8.36 39.81 7.51
SCFAs are expressed as μmol/g wet weight. There were no statistically significant differences between different groups in Experiment I. BCFA, branched-chain fatty acid; B. thet., 
Bacteroides thetaiotaomicron; HF, high-fat diet; LF, low-fat diet; nd, not detected; SCFA, short-chain fatty acid; SEM, standard error of the mean.
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one-way ANOVA), due to a reduction of acetic acid (Table 3). 
The animals in these groups also received B. thetaiotaomicron 
inoculum, but this did not induce any significant change in the 
concentration of SCFAs when administered alone. The concen-
tration of branched-chain fatty acids (BCFAs), isobutyric acid, 
and isovaleric acid decreased in both lactitol and PDX-treated HF 
groups (p < 0.001, one-way ANOVA), and 2-methylbutyric acid 
in lactitol-treated HF group (p < 0.05, one-way ANOVA), when 
compared to the HF control group. These results are presented 
in Table 3.
Dry Matter and heat Value in Feces
Lactitol and PDX in combination with B. thetaiotaomicron 
decreased the dry matter significantly by 19 and 25%, 
respectively, when compared to the HF control group (p < 0.001, 
one-way ANOVA). The heat value increased by 10% in the B. 
thetaiotaomicron-fed animals, when compared to the HF control 
group (p < 0.001, one-way ANOVA). These data are presented 
in Table 3.
Bacteroides in cecal Digesta
The prevalence of Bacteroides spp. in the cecal digesta was quanti-
fied by qPCR in only the group of LF diet-fed animals (Figure 3). 
The high amount of fat in the samples from animals fed the HF 
diet interfered with the microbial DNA extraction, resulting in 
unreliable microbial counts. However, the quantity of Bacteroides 
spp. in the cecal digesta in the LF group supplemented with B. the-
taiotaomicron increased significantly by 11-fold when compared 
FigUre 4 | Postprandial plasma glucose concentrations (millimole/
liter) during the last experimental day expressed separately for 
experiments a (a) and B (B). The values are means with SEM represented 
by vertical bars (n = 4–5). The significant difference is compared to the LF 
control group (-○-) and marked with asterisks: *** p < 0.001 (two-way 
ANOVA). B. thet., Bacteroides thetaiotaomicron; HF, high-fat diet; LF, low-fat 
diet; PDX, polydextrose; SEM, standard error of the mean.
FigUre 3 | The prevalence of Bacteroides spp. in the cecal digesta of 
low-fat (lF) fed animals in experiment a quantified by qPcr. The 
values are mean quantity per gram wet weight with SEM represented by 
vertical bars (n = 3). The significant difference is marked with an asterisk: 
*p < 0.05 (one-way ANOVA). B. thet., Bacteroides thetaiotaomicron; LF, 
low-fat diet; qPCR, quantitative polymerase chain reaction; SEM, standard 
error of the mean.
7
Olli et al. Effect of Lactitol, Polydextrose, and Bacteroides on Metabolism
Frontiers in Nutrition | www.frontiersin.org June 2016 | Volume 3 | Article 15
to the LF control group, showing quantities of 9.76 log10 (SEM 
9.35 log10) and 8.72 log10 (SEM 7.97 log10) cells per gram cecal 
digesta (wet weight), respectively (p < 0.05, one-way ANOVA).
Blood glucose and Triglyceride response
Plasma glucose levels increased shortly after the meal. In the 
LF control group, all glucose values were below 8  mmol/l 
(Figure  4A), which is within the normal postprandial level in 
rats (35). Glucose concentrations tended to be higher in the 
HF control group compared to the LF diet groups, but the only 
significant deviation from the LF control group was measured at 
time point 5 h (p < 0.001, two-way ANOVA), with the glucose 
concentration peaking at 9.84 mmol/l (SEM = 0.73) in the HF 
control group (Figure  4A). Within the LF diet groups, blood 
glucose levels remained low and there was no difference between 
the LF control group and the LF group supplemented with B. 
thetaiotaomicron. Blood glucose levels did not differ between the 
HF diet groups (Figure 4B).
Serum triglycerides decreased significantly (p < 0.05, two-way 
ANOVA) in the groups supplemented with the combination of 
B. thetaiotaomicron and lactitol or B. thetaiotaomicron and PDX 
(Figure 5) at time points 3 and 8 h, respectively. In the HF control 
group, serum triglyceride concentrations peaked earlier (3 h) and 
were higher than with the B. thetaiotaomicron or lactitol-treated 
groups, which both peaked at 5  h time point. In the PDX-
supplemented group, serum triglyceride concentrations peaked 
also at the 3 h time point. There were no significant differences in 
the triglyceride concentrations at time point 0.
Plasma insulin response
No significant differences in the fasting insulin levels (time point 
0  h) were observed between different groups. Plasma insulin 
levels increased shortly after the meal initiation in the HF and 
LF control groups. In the HF groups with B. thetaiotaomicron or 
lactitol supplementation, the acute insulin responses were attenu-
ated, showing decreased insulin levels at time point 1  h, when 
compared to the fasting values of the same group [p =  0.0004 
and p = 0.012, respectively (Student’s t-test)]. Insulin levels in the 
B. thetaiotaomicron and lactitol-supplemented HF groups were 
lower than in the HF control group at time point 1 h [p < 0.01 
and p <  0.001, respectively (two-way ANOVA)] (Figure  6A). 
When the insulin AUC (0–8  h) was examined, the HF group 
administered with lactitol showed significantly lower values than 
the HF control group or the HF group supplemented with B. 
thetaiotaomicron [p = 0.002 and p = 0.048, respectively (Student’s 
t-test)] (Figure 6B).
In comparison to the HF control group, the plasma insulin 
levels decreased 8 h after the meal initiation in animals admin-
istered with either B. thetaiotaomicron alone, or together with 
lactitol or PDX [p < 0.05, p < 0.001, and p < 0.001, respectively 
(two-way ANOVA)] (Figure 6C). No significant differences were 
seen between the groups at other time points and no significant 
peaks appeared. The insulin AUC (0–8 h) decreased significantly 
in lactitol and PDX-enriched groups, compared to the HF control 
FigUre 5 | Postprandial triglyceride concentrations (millimole/liter) in 
experiment B. Samples were taken before the dosage and at 1, 3, 5, and 
8 h after the dosage. The values are means with SEM represented by vertical 
bars (n = 5−10). Significant differences are compared to the HF control 
group (-Δ-) and marked with an asterisk: *p < 0.05 (two-way ANOVA). B. 
thet., Bacteroides thetaiotaomicron; HF, high-fat diet; PDX, polydextrose; 
SEM, standard error of the mean.
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group [p =  0.043 and p =  0.006 respectively (Student’s t-test)] 
(Figure 6D).
PYY release
Plasma PYY concentrations increased significantly in the lactitol-
treated HF group 3–8 h after the final dose, when compared to 
the HF control group (p < 0.01, two-way ANOVA) (Figure 7A). 
A clear peak in PYY levels was seen 3  h after the application 
of lactitol. The PYY AUC (0–8 h) in the lactitol-treated group 
differed significantly from the HF control group and HF 
group supplemented with B. thetaiotaomicron [p = 0.0002 and 
p  =  0.0098, respectively (Student’s t-test)] (Figure  7B). The 
concentration of PYY increased significantly also in the lactitol 
group supplemented with B. thetaiotaomicron 3 h after the final 
dose, when compared to B. thetaiotaomicron group (p < 0.01, 
two-way ANOVA) (Figure  7C). The PYY AUC (0–8  h) of 
this combination group also increased significantly, when 
compared to B. thetaiotaomicron group (p =  0.0008, Student’s 
t-test) (Figure 7D). B. thetaiotaomicron alone did not have any 
significant effect.
DiscUssiOn
This study investigated whether supplementing a diet with rapidly 
fermented lactitol and slowly fermented PDX, with or without 
B. thetaiotaomicron inoculum, influences the metabolism and 
weight maintenance in a rat model. Nutritionally relevant HF diet 
feeding allows the evaluation of anti-obesity intervention that is 
fairly similar to the human condition (34). As expected, the mean 
feed intake differed significantly between LF and HF control 
groups, and the BWG increased in all HF diet groups during the 
acclimatization period, when compared to the corresponding LF 
groups. The HF diet that mimicked the Western human diet was 
used to induce weight gain and an obese phenotype. The HF diet 
contained a moderate HF load: 20% (m/m) from milk fat and 
0.15% (m/m) of supplementary cholesterol. A similar moderate 
HF diet has also been used previously in rat studies (36–38). 
The additive effects of lactitol and PDX on the mean BWG were 
tested when the rats were fed a HF diet. Both lactitol and PDX 
supplementations significantly decreased the feed intake and the 
BWG in HF diet-fed animals. The fiber intake recommendation 
for humans is 25–35 g/day or 3 g/MJ. The equivalent fiber intake 
recommendation for an average adult rat would be ~1.5  g/day 
if the difference in energy consumption between a rat (max 
0.49 MJ) and a human (10.47 MJ) is taken into account (27). The 
doses of lactitol and PDX used in this study (1.6–2 g/animal/day) 
were close to these recommended values.
The heat value of feces increased in animals supplemented 
with B. thetaiotaomicron, when compared to other groups, 
indicating that more energy was present in the feces. This would 
support the initial hypothesis that high amounts of intestinal 
Bacteroidetes could help to maintain a low body weight. This 
effect may be mediated through changes in the composition of 
the gut microbiota or through microbial metabolites. However, 
the fecal heat value of animals that were given B. thetaiotaomicron 
with lactitol or PDX did not increase. The percentage of fecal dry 
matter decreased in lactitol and PDX-supplemented animals with 
more moist feces in these groups.
The potential effect of Bacteroides as a probiotic together with 
fermentable fibers was studied in an animal model. Previously, 
the synbiotic effects of lactitol with another microbial strain, 
Lactobacillus NCFM®, have been successfully tested in vitro and 
in human clinical trials with proven beneficial effects on the gut 
microbiota and its activity (39, 40). Studies with B. thetaiotaomi-
cron have revealed that co-colonization with other microbial 
species can enhance the efficiency and change the specificity 
of bacterial polysaccharide fermentation (41). In the present 
study, the increased fermentation of indigestible carbohydrates 
was not detected with Bacteroides supplementation. In addition, 
B. thetaiotaomicron increased fecal energy value. On the other 
hand, the BWG and plasma triglyceride concentrations were 
decreased by lactitol and PDX, when supplemented with B. 
thetaiotaomicron. The dietary fat content is also known to affect 
the microbiome; i.e., reduced levels of Bacteroidetes are reported 
in mice fed a HF diet and linked to an increased risk of obesity 
(23, 42). In our study, the impact of B. thetaiotaomicron on the 
detected higher quantities of Bacteroides spp. was significant in LF 
diet-fed animals, indicating that the dose of B. thetaiotaomicron 
had successfully passed through the gastrointestinal tract. The 
method of gavaging B. thetaiotaomicron has been demonstrated 
previously as a reliable and efficient way to ensure colonization 
(41). A limitation of our study, however, was with the use of only 
one strain of Bacteroides spp., while the Bacteroidetes phylum 
comprises a wide range of strains with different properties. 
Therefore, the administration of one single strain of Bacteroides 
spp. over a relatively short time proved not to be sufficient enough 
to counteract the effects of a HF diet.
The HF diet resulted in a marginally lower concentration of 
total SCFAs compared to a LF containing diet. In animals fed 
the HF diet, lactitol and PDX decreased the total cecum SCFAs, 
mostly due to the highly reduced level of acetic acid. Decreased 
FigUre 6 | Postprandial plasma insulin concentrations (picogram/milliliter) during the last experimental day, expressed separately for experiments 
a (a) and B (c). The areas under the curve (AUC) for insulin concentrations in both experiments are expressed in (B,D). The AUC values (0–8 h after the last dose) 
were calculated using the trapezoidal rule. The values are means with SEM represented by vertical bars (n = 4–5). The significant differences are compared to the 
HF control group (-Δ-) at the same time point or between the indicated groups and marked with asterisks: *p < 0.05, **p < 0.01, and ***p < 0.001 (two-way ANOVA 
for insulin concentrations and Student’s t-test for AUC). In figure (a), the statistically significant values are marked with a circle. B. thet., Bacteroides 
thetaiotaomicron; HF, high-fat diet; LF, low-fat diet; PDX, polydextrose; SEM, standard error of the mean.
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SCFA concentrations with lactitol and PDX have been reported 
previously in rodents (32, 43). The concentration of BCFAs, 
including isobutyric and isovaleric acid, was decreased by both 
lactitol and PDX, indicating less protein fermentation in these 
groups. A similar decrease in the relative concentration of BCFAs, 
isobutyric acid and isovaleric acid, by the addition of lactitol and 
PDX has been noted previously (32). However, no significant 
effect of the tested supplements on the absolute concentration of 
butyric acid was seen in the present study. Interestingly, in vitro 
studies with a semi-continuous four-stage colon simulator model 
have demonstrated that PDX has great potential to increase SCFAs 
in the gut (7, 44). One explanation to the low SCFA concentra-
tion detected in the present study could be the “snapshot” nature 
of the analysis, demonstrating the state of measured SCFAs at a 
particular time point (8 h after the last dosage) in only a single 
sample of digesta per animal. Also, an increase of the cecal volume 
could be one explanation for the reduced SCFA concentrations, as 
suggested before (32). However, cecal weight was not measured 
in the present study.
Fermentation of indigestible carbohydrates has been shown to 
affect glycemic responses and satiety (45). The modulation of the 
postprandial lipid concentrations by indigestible carbohydrates 
has not been widely investigated. In the present study, lactitol had 
already lowered the serum triglycerides 3 h after the last dose was 
given, when it was used in combination with B. thetaiotaomicron. 
With lactitol, the postprandial triglyceride response was lower 
and peaked later than with the control group, therefore, weaken-
ing the postprandial rise of triglycerides. PDX supplemented with 
B. thetaiotaomicron reduced the serum triglyceride concentration 
significantly 8 h after the last dose was given. PDX also marginally 
lowered the immediate triglyceride response. Hence, our data 
suggest that lactitol and PDX potentially have an attenuating 
effect on the postprandial triglyceride response in rats fed a HF 
diet. Previous human studies have also shown that a combination 
FigUre 7 | Postprandial plasma PYY concentrations (picogram/milliliter) during the last experimental day, expressed separately for experiments a 
(a) and B (c). The areas under the curve (AUC) for PYY concentrations in both experiments are expressed in (B,D). The AUC values (0–8 h after the last dose) were 
calculated using the trapezoidal rule. The values are means with SEM represented by vertical bars (n = 4–5). The significant differences are compared to the HF 
control group (-Δ-) in (a), to B. thetaiotaomicron group (-▲-) in (c), or between the indicated groups in (B,D), and marked with asterisks: **p < 0.01, *** p < 0.001 
(two-way ANOVA for insulin concentrations and Student’s t-test for AUC). B. thet., Bacteroides thetaiotaomicron; HF, high-fat diet; LF, low-fat diet; PDX, 
polydextrose; PYY, peptide tyrosine tyrosine; SEM, standard error of the mean.
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of PDX and lactitol (46), or PDX alone (47) have reduced the level 
of postprandial serum triglycerides. Since triglycerides are an 
energy source during metabolism, the reduction of triglycerides 
in circulation with dietary supplements, such as lactitol or PDX, 
could be beneficial for weight management and reducing the risk 
of cardiovascular disease. Even though rat is a commonly used 
model for metabolic disease studies, conclusions concerning 
triglyceride responses in humans should be drawn with the great 
care (48). In addition, differences in postprandial triglyceride 
responses between genders have been reported in rat studies (49), 
and this has to be taken into consideration when evaluating the 
triglyceride effects of potential food ingredients in rats.
Dietary proteins and fibers are known to affect insulin secre-
tion (50, 51). PDX has shown to maintain low postprandial blood 
glucose levels (26) and lactitol has a low glycemic and insulinemic 
index (52). In the present study, a HF diet increased glucose lev-
els, when compared to a LF diet that validates the model used in 
this study. Here, we showed that the pre-meal ingestion of both 
lactitol and PDX significantly decreased insulin AUC (0–8  h), 
but had no effect on glucose levels. Interestingly, in both experi-
ments the postprandial plasma PYY levels consistently increased 
3 h after the ingestion of lactitol when in combination with B. 
thetaiotaomicron. A similar effect with lactitol has been demon-
strated previously (15). However, no direct effect of Bacteroides 
or PDX on PYY levels was noted in the present study. According 
to previous animal studies, the addition of prebiotic fibers in HF 
diets fed to rats was able to increase satiety hormone levels and 
reduce BWG (53). Therefore, managing postprandial glucose and 
insulin responses with prebiotic supplements could help decrease 
the risk of metabolic diseases and also play a role in body weight 
management in humans.
In conclusion, the HF diet had detrimental effects on glucose 
metabolism and body weight but the two indigestible carbo-
hydrates tested in this study, lactitol and PDX, may provide an 
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additional means of regulating weight management and post-
prandial metabolism, especially via the triglyceride response. In 
addition, lactitol significantly increased the PYY satiety hormone 
levels. However, the oral administration of a single strain of B. 
thetaiotaomicron had a minor or no effect on metabolism.
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